0001209191-23-058717.txt : 20231215 0001209191-23-058717.hdr.sgml : 20231215 20231215082339 ACCESSION NUMBER: 0001209191-23-058717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCall Patrick CENTRAL INDEX KEY: 0001874384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 231488839 MAIL ADDRESS: STREET 1: C/O IN8BIO, INC. STREET 2: 79 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-13 0 0001740279 IN8BIO, INC. INAB 0001874384 McCall Patrick C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330 NEW YORK NY 10118 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-12-13 4 A 0 20492 A 26755 D Series A Warrants (right to buy) 1.25 2023-12-13 4 A 0 20492 A 2025-06-13 Common Stock 20492 20492 D Series B Warrants (right to buy) 1.50 2023-12-13 4 A 0 20492 A 2028-12-13 Common Stock 20492 20492 D The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock. Fully vested and exercisable. /s/ Jason Minio, Attorney-in-Fact 2023-12-15